ITMI20022777A1 - Formulazioni farmaceutiche per ormoni tiroidei e procedimenti per il loro ottenimento. - Google Patents

Formulazioni farmaceutiche per ormoni tiroidei e procedimenti per il loro ottenimento.

Info

Publication number
ITMI20022777A1
ITMI20022777A1 IT002777A ITMI20022777A ITMI20022777A1 IT MI20022777 A1 ITMI20022777 A1 IT MI20022777A1 IT 002777 A IT002777 A IT 002777A IT MI20022777 A ITMI20022777 A IT MI20022777A IT MI20022777 A1 ITMI20022777 A1 IT MI20022777A1
Authority
IT
Italy
Prior art keywords
procedures
obtaining
thyroid hormones
pharmaceutical formulations
thyroid
Prior art date
Application number
IT002777A
Other languages
English (en)
Inventor
Martino Alessandro Di
Alberto Garavani
Maurizio Marchiorri
Angel Mateo
Original Assignee
Altergon Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32448935&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ITMI20022777(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Altergon Sa filed Critical Altergon Sa
Priority to IT002777A priority Critical patent/ITMI20022777A1/it
Priority to ES03029729T priority patent/ES2334777T3/es
Priority to US10/746,386 priority patent/US7691411B2/en
Priority to AT03029729T priority patent/ATE447939T1/de
Priority to EP03029729A priority patent/EP1433478B1/en
Priority to DE60329968T priority patent/DE60329968D1/de
Priority to CA2454050A priority patent/CA2454050C/en
Priority to DK03029729.5T priority patent/DK1433478T3/da
Priority to SI200331747T priority patent/SI1433478T1/sl
Priority to JP2003432097A priority patent/JP4851064B2/ja
Publication of ITMI20022777A1 publication Critical patent/ITMI20022777A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
IT002777A 2002-12-27 2002-12-27 Formulazioni farmaceutiche per ormoni tiroidei e procedimenti per il loro ottenimento. ITMI20022777A1 (it)

Priority Applications (10)

Application Number Priority Date Filing Date Title
IT002777A ITMI20022777A1 (it) 2002-12-27 2002-12-27 Formulazioni farmaceutiche per ormoni tiroidei e procedimenti per il loro ottenimento.
SI200331747T SI1433478T1 (sl) 2002-12-27 2003-12-23 Farmacevtske formulacije za tiroidne hormone in postopki za njihovo pripravo
EP03029729A EP1433478B1 (en) 2002-12-27 2003-12-23 Pharmaceutical formulae for thyroid hormones and procedures for obtaining them
US10/746,386 US7691411B2 (en) 2002-12-27 2003-12-23 Pharmaceutical formulae for thyroid hormones and procedures for obtaining them
AT03029729T ATE447939T1 (de) 2002-12-27 2003-12-23 Dosierungsformen enthaltend thyroidhormone und deren herstellungsverfahren
ES03029729T ES2334777T3 (es) 2002-12-27 2003-12-23 Formulas farmaceuticas para hormonas tiroideas y procedimientos para su obtencion.
DE60329968T DE60329968D1 (de) 2002-12-27 2003-12-23 Dosierungsformen enthaltend Thyroidhormone und deren Herstellungsverfahren
CA2454050A CA2454050C (en) 2002-12-27 2003-12-23 Pharmaceutical formulae for thyroid hormones and procedures for obtaining them
DK03029729.5T DK1433478T3 (da) 2002-12-27 2003-12-23 Farmaceutiske formler til thyroidhormoner og fremgangsmåder til opnåelse af disse
JP2003432097A JP4851064B2 (ja) 2002-12-27 2003-12-26 甲状腺ホルモン用医薬形態およびそれを得るための方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT002777A ITMI20022777A1 (it) 2002-12-27 2002-12-27 Formulazioni farmaceutiche per ormoni tiroidei e procedimenti per il loro ottenimento.

Publications (1)

Publication Number Publication Date
ITMI20022777A1 true ITMI20022777A1 (it) 2004-06-28

Family

ID=32448935

Family Applications (1)

Application Number Title Priority Date Filing Date
IT002777A ITMI20022777A1 (it) 2002-12-27 2002-12-27 Formulazioni farmaceutiche per ormoni tiroidei e procedimenti per il loro ottenimento.

Country Status (10)

Country Link
US (1) US7691411B2 (it)
EP (1) EP1433478B1 (it)
JP (1) JP4851064B2 (it)
AT (1) ATE447939T1 (it)
CA (1) CA2454050C (it)
DE (1) DE60329968D1 (it)
DK (1) DK1433478T3 (it)
ES (1) ES2334777T3 (it)
IT (1) ITMI20022777A1 (it)
SI (1) SI1433478T1 (it)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7163918B2 (en) * 2000-08-22 2007-01-16 New River Pharmaceuticals Inc. Iodothyronine compositions
ITMI20110713A1 (it) 2011-04-29 2012-10-30 Bracco Imaging Spa Processo per la preparazione di un derivato solfatato di3,5-diiodo-o-[3-iodofenil]-l-tirosina
ITMI20022394A1 (it) 2002-11-13 2004-05-14 Bracco Spa Uso di triiodotironina 3-solfato come farmaco ad attivita' tireomimetica e relative formulazioni farmaceutiche.
WO2005051298A2 (en) * 2003-11-19 2005-06-09 Metabasis Therapeutics, Inc. Novel phosphorus-containing thyromimetics
ITMI20041317A1 (it) * 2004-06-30 2004-09-30 Ibsa Inst Biochimique Sa Formulazioni farmaceutiche per la somministrazione sicura di farmaci utilizzati nel trattamento della tossicodipendenza e procedimento per il loro ottenimento
MX2007014501A (es) * 2005-05-26 2008-02-07 Metabasis Therapeutics Inc Tiromimeticos novedosos que contienen acido fosfinico.
CA2606499C (en) 2005-05-26 2017-06-13 Metabasis Therapeutics, Inc. Thyromimetics for the treatment of fatty liver diseases
IT1395454B1 (it) * 2009-03-24 2012-09-21 Altergon Sa Composizioni e forme farmaceutiche per somministrazione orale di ormoni tiroidei in grado di contrastare l'azione di agenti sequestranti nel tratto gastrointestinale
WO2016185378A1 (en) * 2015-05-19 2016-11-24 Altergon S.A. Liquid pharmaceutical formulations of tetraiodothyronine
KR20190104524A (ko) 2016-11-21 2019-09-10 바이킹 테라퓨틱스 인코포레이티드 당원축적질환의 치료 방법
KR102600115B1 (ko) 2017-06-05 2023-11-09 바이킹 테라퓨틱스 인코포레이티드 섬유증 치료를 위한 조성물
EP3768690A4 (en) 2018-03-22 2021-11-24 Viking Therapeutics, Inc. CRYSTALLINE SHAPES AND METHOD FOR MAKING CRYSTALLINE SHAPES OF A COMPOUND
CA3171512A1 (en) * 2020-03-18 2022-09-23 Rickey Steve Shelley Softgel capsules

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6191M (it) 1966-02-18 1968-07-22
DE4026600A1 (de) * 1990-08-23 1992-02-27 Henning Berlin Gmbh Mittel zur tsh-suppression und behandlung von struma
JPH0952850A (ja) * 1995-06-09 1997-02-25 Meiji Seika Kaisha Ltd グミ製剤
JPH10130140A (ja) * 1996-11-01 1998-05-19 Meiji Seika Kaisha Ltd グミ製剤の製造方法
US6365180B1 (en) * 1998-01-20 2002-04-02 Glenn A. Meyer Oral liquid compositions
AU772153B2 (en) * 1999-02-12 2004-04-08 Molecular Insight Pharmaceuticals, Inc. Matrices for drug delivery and methods for making and using the same
JP2000279107A (ja) * 1999-03-30 2000-10-10 Lion Corp 非う蝕性易嚥下組成物並びにそれを用いた食品用組成物及び医薬品用組成物
US6852688B2 (en) * 2000-03-10 2005-02-08 University Of Florida Compositions for treating diabetic retinopathy and methods of using same
US6790453B2 (en) * 2001-03-14 2004-09-14 Mccormick & Company, Inc. Encapsulation compositions and process for preparing the same
GB0111314D0 (en) 2001-05-09 2001-07-04 Karobio Ab Dermatological formulations
ITMI20011401A1 (it) 2001-07-02 2003-01-02 Altergon Sa Formulazioni farmaceutiche per ormoni tiroidei

Also Published As

Publication number Publication date
SI1433478T1 (sl) 2010-03-31
EP1433478A1 (en) 2004-06-30
ATE447939T1 (de) 2009-11-15
DK1433478T3 (da) 2010-02-01
US7691411B2 (en) 2010-04-06
DE60329968D1 (de) 2009-12-24
US20040219218A1 (en) 2004-11-04
EP1433478B1 (en) 2009-11-11
JP4851064B2 (ja) 2012-01-11
CA2454050C (en) 2013-01-29
ES2334777T3 (es) 2010-03-16
JP2004210780A (ja) 2004-07-29
CA2454050A1 (en) 2004-06-27

Similar Documents

Publication Publication Date Title
NO20063430L (no) Generelt lineaer, brusende oral fentanyl doseringsform, og metoder for administrering
NO20062504L (no) Sammensetninger og doseringsformer for forbedret absorpsjon
SE0301700D0 (sv) Novel compounds
NO20063429L (no) Brusende oral opiat doseringsform
WO2005115406A3 (en) 8-(2-hydroxyphenoxy)octyldiethanolamine and salts thereof for delivery of active agents
CY1106430T1 (el) Φαρμακα για εισπνοη που πepιλαμβανουν βηταμιμητικα και αντιχολινepγικο
HRP20041152B1 (en) Pharmaceutical formulations
CY1112721T1 (el) Νεοι συνδετες που διαμορφωνουν τους υποδοχεις rαr, και χρηση αυτων στην ιατρικη για τον ανθρωπο και στα καλλυντικα
ATE413162T1 (de) Pharmazeutische zusammensetzungen zur sicheren verabreichung von bei der behandlung von drogenabhängigkeit verwendeten arzneimitteln
CY1108067T1 (el) Υποκατεστημενα παραγωγα 2-πυριδινο-κυκλοεξανο-1,4-διαμινης
WO2007149406A8 (en) Modified coagulation factor ix polypeptides and use thereof for treatment
ITMI20022777A1 (it) Formulazioni farmaceutiche per ormoni tiroidei e procedimenti per il loro ottenimento.
CR7362A (es) Formulaciones farmaceuticas de derivado de platino
ATE312621T1 (de) Pharmazeutische formulierungen von thyroidhormonen
CY1109366T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης
CY1105028T1 (el) Υποκατεστημενες c-ιμιδαζο-[1,2-α]πυριδιν-3-υλο-μεθυλαμινες
NO331082B1 (no) Formulering av kahalalid F, sett omfattende en slik formulering, samt rekonstituert losning derav og anvendelse av en fortynnet rekonstituert losning til fremstilling av et medikament for behandling av kreft
CY1107231T1 (el) Υποκατεστημενα παραγωγα 4-αμινοκυκλοεξανολης
CY1105019T1 (el) Υποκατεστημενες c-ιμιδαζο-[1,2-α]πυριδιν-3-υλο-μεθυλαμινες
EP1503748A4 (en) DRUGS TO REDUCE TAXAN-INDUCED NEUROTOXICITY
SE0200657D0 (sv) Novel Formulation
DE60311665D1 (de) Pharmazeutische zusammensetzungen
TW200611697A (en) Generally linear effervescent oral fentanyl dosage form and methods of administering
ATE338567T1 (de) Pharmazeutische zubereitungen, wirkstoffe enthaltend, die sich für unerlaubte verabreichung anbieten
ATE530172T1 (de) Pharmazeutische formulierungen mit clopidogrel